1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,360 | 1,500 | 10:40 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.09. | ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD 2 Million | 259 | Business Wire | Regulatory News:
ALIKO Scientific (Ikonisys SA Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces that its wholly-owned... ► Artikel lesen | |
| 15.09. | Aliko Scientific Launches Probantes in Brazil and Establishes a New Molecular Diagnostic Development and Commercial Platform for South America | 380 | Business Wire | Currently being established in Brazil, Probantes is wholly owned by Aliko Scientific and based in Anápolis, Goiás, a major pharmaceutical and life sciences hub.
Probantes will serve... ► Artikel lesen | |
| 07.09. | Aliko Scientific Successfully Launches U.S. Business Development Collaboration With Partner International at ADLM 2026, the World's Largest Molecular Diagnostics Exhibition | 362 | Business Wire | Strong first joint initiative at ADLM (Association for Diagnostics Laboratory Medicine) 2026, providing direct access to major international diagnostics players Significant interest generated... ► Artikel lesen | |
| 24.08. | Aliko Scientific Provides a Financial Update Following the Publication of its FY 2025 Results and Reaffirms Its Business Momentum | 661 | Business Wire | Regulatory News:
ALIKO Scientific (Ikonisys SA Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, today provides additional financial... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 05.08. | Aliko Scientific Signs New Distribution Agreements in Romania and Saudi Arabia, Strengthening Its International Commercial Network | 823 | Business Wire | €1.92 million in Romania and €2.05 million in Saudi Arabia in five-year minimum contractual purchase commitments Agreements covering Aliko Scientific's liquid-based cytology, FISH, microscopy... ► Artikel lesen | |
| 05.08. | XFRA 9W8: WIEDERAUFNAHME/RESUMPTION | 180 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 30.07. | Aliko Scientific Reports its Full-Year Financial Results for 2025 and Provides an Update on Its Latest Developments | 826 | Business Wire | Total revenue up 52.6% to €1.64 million (vs. €1.08 million in 2024), driven by Hospitex' full-year contribution and the progressive rollout of Aliko Scientific's offering
EBITDA improved... ► Artikel lesen | |
| 23.07. | Aliko Scientific Tochter unterzeichnet Vereinbarung für Krebs-Screening in Usbekistan | - | Investing.com Deutsch | ||
| 23.07. | Aliko Scientific unit signs Uzbekistan cancer screening deal | 2 | Investing.com | ||
| 23.07. | Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project | 380 | Business Wire | Confirmation of the growing international interest in Urine24 and significant recognition of Aliko Scientific's expertise in large-scale oncological diagnostic solutions Immediate launch... ► Artikel lesen | |
| 15.06. | XFRA 9W8: AUSSETZUNG/SUSPENSION | 176 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 0,5... ► Artikel lesen | |
| 25.05. | Aliko Scientific gründet Joint Venture in Brasilien zur Herstellung von FISH-Sonden | 1 | Investing.com Deutsch | ||
| 25.05. | Aliko Scientific signs Brazil JV to manufacture FISH probes | 1 | Investing.com | ||
| 25.05. | Aliko Scientific SA: Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture | 552 | Business Wire | Aliko Scientific signs Brazilian JV with BioBrasil to manufacture proprietary FISH probes for global diagnostic markets New "instrument probes" model aims to create recurring revenues and... ► Artikel lesen | |
| 19.05. | Aliko Scientific SA: Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital | 424 | Business Wire | Execution of the long-term strategy focused on recurring revenue and developing opportunities for sustainable growth Contract with a potential total value of approximately €620,000, over... ► Artikel lesen | |
| 11.05. | Aliko Scientific SA: Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona | 508 | Business Wire | Regulatory News:
Aliko Scientific SA ("Aliko Scientific" or the "Company") (Euronext Growth Paris: ALIKO), an industrial and financial holding company focused on advanced oncology diagnostics... ► Artikel lesen | |
| 10.03. | Aliko Scientific: Hospitex International Signs Strategic Distribution Agreement With Naturneed for Urine24, Strengthening Its Commercial Footprint in the Italian Urology Diagnostics Market | 557 | Business Wire | Regulatory News:
Hospitex International, part of Aliko Scientific Group (Ticker: ALIKO), announces the signing of a strategic distribution agreement with Naturneed for the commercialization... ► Artikel lesen | |
| 24.02. | Aliko Scientific: Outstanding Success at WHX Labs Dubai With 172 Commercial Leads and Strong Global Interest in the New Integrated Oncology Diagnostics Platform | 513 | Business Wire | Regulatory News:
Aliko Scientific SA (Ticker: ALIKO) previously Ikonisys SA, announces a highly successful first market appearance at WHX Labs Dubai, the world's largest medical trade exhibition... ► Artikel lesen | |
| 18.02. | Aliko Scientific: Francesco Trisolini Appointed as New Group CEO to Pursue the Implementation of the Approved Industrial Plan | 568 | Business Wire | Regulatory News:
Aliko Scientific SA (Ikonisys SA Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
| 19.12.25 | Ikonisys SA: Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali | 559 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| FRESENIUS | 42,485 | +2,15 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,450 | +1,99 % | Fresenius Medical Care: Helen Giza verlässt den Konzern - Nachfolger steht fest | Bad Marienberg (www.anleihencheck.de) - Ad hoc-Mitteilung der Fresenius Medical Care AG vom 07.10.2026:Der Aufsichtsrat der Fresenius Medical Care AG hat heute einstimmig beschlossen, Shervin J. Korangy... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| NEUROPACE | 12,390 | 0,00 % | KeyBanc initiates NeuroPace stock coverage with overweight rating |
Das Unternehmen IKONISYS SA kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,49 % bei einem Aktienkurs von 1,360 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS SA finden Sie auf Wallstreet Online.